Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
Please Note: These Activities are No Longer Available for Credit
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA